Gyre Therapeutics (GYRE) Return on Sales [ROS] (2009 - 2026)
Gyre Therapeutics (GYRE) reported Return on Sales [ROS] of -49.35% for Q2 2026, down 41.82 percentage points from -7.53% a year earlier and down 7.81 percentage points from the prior quarter.
Powered by 
Analysis
Gyre Therapeutics (GYRE) Return on Sales [ROS] (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Gyre Therapeutics' Return on Sales [ROS] came in at -13.97%, down 18.66 percentage points year-over-year; for FY2025, it was 9.85%, down 5.43 percentage points from FY2024.
- Return on Sales [ROS] has a five-year change of +283.72 percentage points (FY2020 to FY2025).
- By year, Return on Sales [ROS] came in at 15.28% in FY2024 (+74.54 pp), -59.26% in FY2023 (-68.26 pp), 9.00% in FY2022 (+1206.79 pp) and -1197.79% in FY2021 (-923.92 pp).
- The Q2 2026 figure ranks as the lowest quarterly Return on Sales [ROS] since Q4 2023.
- Year over year, Return on Sales [ROS] has now declined in each of the last three quarters, with an average year-over-year change of +23.43 percentage points over the last eight quarters.
- The high point for year-over-year Return on Sales [ROS] in five years was Q1 2023 (a gain of 1878.24 percentage points); the low point was Q1 2022 (a drop of 322.00 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -41.54% (Q1 2026), 0.32% (Q4 2025) and 22.66% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | Gyre Therapeutics | 487.81 Mn | 295.13 Mn | 30.99 Mn | -4.62% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -4.62% |
| Jun 30, 2026 | -49.35% |
| Mar 31, 2026 | -41.54% |
| Dec 31, 2025 | 41.08% |
| Sep 30, 2025 | 4.57% |
| Jun 30, 2025 | -7.53% |
| Mar 31, 2025 | 10.30% |
| Dec 31, 2024 | 2.39% |
| Sep 30, 2024 | 16.61% |
| Jun 30, 2024 | 12.66% |
| Mar 31, 2024 | 29.70% |
| Dec 31, 2023 | -337.53% |
| Sep 30, 2023 | 39.84% |
| Jun 30, 2023 | 16.96% |
| Mar 31, 2023 | 26.73% |
| Dec 31, 2022 | -22.13% |
| Sep 30, 2022 | 350.96% |
| Jun 30, 2022 | -157.47% |
| Mar 31, 2022 | -1,851.51% |
| Dec 31, 2021 | -832.50% |
API Access
Gyre Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=GYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "GYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=GYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();